QQ客服 官方微博 反馈留言

浏览/检索结果: 共4条，第1-4条 帮助 限定条件 发表日期：2016     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Survival benefit of anti-HER2 therapy after whole-brain radiotherapy in HER2-positive breast cancer patients with brain metastasis 期刊论文 BREAST CANCER, 2016, 卷号: 23, 期号: 5 作者:  Zhang, Qian;  Chen, Jian;  Yu, Xiaoli;  Cai, Gang;  Yang, Zhaozhi 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05 Breast cancer  Brain metastasis  Human epidermal growth factor receptor 2 (HER2)-positive breast cancer  Whole-brain radiotherapy  Survival   SIN1 promotes the proliferation and migration of breast cancer cells by Akt activation 期刊论文 BIOSCIENCE REPORTS, 2016, 卷号: 36, 期号: 6 作者:  Wang, Deqiang[1];  Wu, Ping[2];  Wang, Hui[3];  Zhu, Lei[4];  Zhao, Wei[5] 收藏  |  浏览/下载：9/0  |  提交时间：2019/12/24 breast cancer  cell proliferation  human epidermal growth factor receptor 2 (HER2)  migration  stress-activated protein kinase interacting protein 1 (SIN1)  survival   Outcomes of re-treatment with first-line Trastuzumab plus a taxane in HER2 positive metastatic breast cancer patients after (neo)adjuvant Trastuzumab: A prospective multicenter study 期刊论文 ONCOTARGET, 2016, 卷号: 7, 期号: 31 作者:  Xu, Binghe;  Hu, Xichun;  Zheng, Hong;  Wang, Xiaojia;  Zhang, Qingyuan 收藏  |  浏览/下载：10/0  |  提交时间：2019/12/06 trastuzumab  human epidermal growth factor receptor 2 (HER2)  metastatic breast cancer  (Neo)adjuvant trastuzumab  relapse  re-treatment   Outcomes of re-treatment with first-line Trastuzumab plus a taxane in HER2 positive metastatic breast cancer patients after (neo)adjuvant Trastuzumab: A prospective multicenter study 期刊论文 2016, 卷号: 7, 期号: 31, 页码: 50643-50655 作者:  Xu, Binghe;  Hu, Xichun;  Zheng, Hong;  Wang, Xiaojia;  Zhang, Qingyuan 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04 trastuzumab  human epidermal growth factor receptor 2 (HER2)  metastatic breast cancer  (Neo)adjuvant trastuzumab  relapse  re-treatment